These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 11883777)

  • 1. NMR-based structural characterization of large protein-ligand interactions.
    Pellecchia M; Meininger D; Dong Q; Chang E; Jack R; Sem DS
    J Biomol NMR; 2002 Feb; 22(2):165-73. PubMed ID: 11883777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NMR-based techniques in the hit identification and optimisation processes.
    Pellecchia M; Becattini B; Crowell KJ; Fattorusso R; Forino M; Fragai M; Jung D; Mustelin T; Tautz L
    Expert Opin Ther Targets; 2004 Dec; 8(6):597-611. PubMed ID: 15584865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NMR spectroscopy tools for structure-aided drug design.
    Homans SW
    Angew Chem Int Ed Engl; 2004 Jan; 43(3):290-300. PubMed ID: 14705081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NMR in structure-based drug design.
    Carneiro MG; Ab E; Theisgen S; Siegal G
    Essays Biochem; 2017 Nov; 61(5):485-493. PubMed ID: 29118095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NMR studies of protein-ligand interactions.
    Maurer T
    Methods Mol Biol; 2005; 305():197-214. PubMed ID: 15939999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NMR-based methods and strategies for drug discovery.
    Salvatella X; Giralt E
    Chem Soc Rev; 2003 Nov; 32(6):365-72. PubMed ID: 14671791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ligand-Orientation Based Fragment Selection in STD NMR Screening.
    Cala O; Krimm I
    J Med Chem; 2015 Nov; 58(21):8739-42. PubMed ID: 26492576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct NMR Probing of Hydration Shells of Protein Ligand Interfaces and Its Application to Drug Design.
    Geist L; Mayer M; Cockcroft XL; Wolkerstorfer B; Kessler D; Engelhardt H; McConnell DB; Konrat R
    J Med Chem; 2017 Nov; 60(21):8708-8715. PubMed ID: 28910100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Object-oriented approach to drug design enabled by NMR SOLVE: first real-time structural tool for characterizing protein-ligand interactions.
    Sem DS; Yu L; Coutts SM; Jack R
    J Cell Biochem Suppl; 2001; Suppl 37():99-105. PubMed ID: 11842434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein-ligand structure determination with the NMR molecular replacement tool, NMR
    Orts J; Riek R
    J Biomol NMR; 2020 Nov; 74(10-11):633-642. PubMed ID: 32621003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NMR in drug discovery: A practical guide to identification and validation of ligands interacting with biological macromolecules.
    Gossert AD; Jahnke W
    Prog Nucl Magn Reson Spectrosc; 2016 Nov; 97():82-125. PubMed ID: 27888841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding site identification and structure determination of protein-ligand complexes by NMR a semiautomated approach.
    Ziarek JJ; Peterson FC; Lytle BL; Volkman BF
    Methods Enzymol; 2011; 493():241-75. PubMed ID: 21371594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ID NMR Methods in ligand-receptor interactions.
    Zartler ER; Yan J; Mo H; Kline AD; Shapiro MJ
    Curr Top Med Chem; 2003; 3(1):25-37. PubMed ID: 12577989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Applications of SHAPES screening in drug discovery.
    Lepre CA; Peng J; Fejzo J; Abdul-Manan N; Pocas J; Jacobs M; Xie X; Moore JM
    Comb Chem High Throughput Screen; 2002 Dec; 5(8):583-90. PubMed ID: 12470255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SOS-NMR: a saturation transfer NMR-based method for determining the structures of protein-ligand complexes.
    Hajduk PJ; Mack JC; Olejniczak ET; Park C; Dandliker PJ; Beutel BA
    J Am Chem Soc; 2004 Mar; 126(8):2390-8. PubMed ID: 14982445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NMR structure determination of protein-ligand complexes by lanthanide labeling.
    Pintacuda G; John M; Su XC; Otting G
    Acc Chem Res; 2007 Mar; 40(3):206-12. PubMed ID: 17370992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NMR spectroscopy and protein structure determination: applications to drug discovery and development.
    Wishart D
    Curr Pharm Biotechnol; 2005 Apr; 6(2):105-20. PubMed ID: 15853690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complete relaxation and conformational exchange matrix (CORCEMA) analysis of intermolecular saturation transfer effects in reversibly forming ligand-receptor complexes.
    Jayalakshmi V; Krishna NR
    J Magn Reson; 2002 Mar; 155(1):106-18. PubMed ID: 11945039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solution NMR of large molecules and assemblies.
    Foster MP; McElroy CA; Amero CD
    Biochemistry; 2007 Jan; 46(2):331-40. PubMed ID: 17209543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigating Protein-Ligand Interactions by Solution Nuclear Magnetic Resonance Spectroscopy.
    Becker W; Bhattiprolu KC; Gubensäk N; Zangger K
    Chemphyschem; 2018 Apr; 19(8):895-906. PubMed ID: 29314603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.